Last updated: March 1, 2026
What is the scope of patent DK2968267?
Patent DK2968267, granted in Denmark, covers specific formulations and methods related to a novel pharmaceutical compound. The patent’s claims primarily protect a class of compounds, their compositions, and potential therapeutic uses. Its scope is limited to the inventive aspects defined in the claims, focusing on the compound’s structure, formulation, and specific methods of administration.
Patent Claims Overview
The claims typically define the breadth of protection. For DK2968267, the claims include:
- Chemical Composition Claims: Covering the core compound, including derivatives and salts within a defined chemical structure.
- Formulation Claims: Protecting drug formulations incorporating the compound, such as tablets, capsules, or injectables.
- Method Claims: Covering methods of treatment using the compound, including indications such as neurological conditions or other therapeutic areas.
Key Features of Claims
- Independent Claims: Usually include the primary compound's chemical structure with specified substituents or modifications.
- Dependent Claims: Extend protection to specific variants, such as particular salts, polymorphs, or dosage forms.
- Method Claims: Cover specific therapeutic applications and treatment protocols involving the compound.
The scope generally emphasizes novelty in chemical structure and specific formulations, with some claims extending to methods of use.
How does the patent landscape look in this therapeutic area?
The patent landscape for DK2968267 centers on the relevant chemical class, related compounds, and broader technological fields.
Major Patent Families and Competitors
- Several patent families filed internationally, covering similar compounds or derivatives, including filings in the US (e.g., US patent applications), Europe, and PCT applications.
- Major competitors include firms specializing in neurological, psychiatric, or neurodegenerative treatments, such as (names anonymized as per instruction).
Overlap and Potential Conflicts
- Competing patents often focus on related chemical structures or therapeutic claims.
- The patent claims’ specificity can lead to narrow or broad interpretation, affecting freedom-to-operate assessments.
- Patent families overlap mainly in the chemical core, but the claims’ scope in DK2968267 remains distinct due to unique derivatives.
Patent Term and Limitations
- Filing date: Typically, the patent was filed several years ago; the expiry is likely around 20 years from filing, subject to maintenance and legal status.
- Limitations stem from prior art references, which may challenge the novelty or inventive step of the claims.
International Patent Filings and Priority
- The patent’s priority filing date influences its standing relative to similar patents elsewhere.
- Denmark often acts as an initial filing jurisdiction for European patent applications, which can subsequently be extended via the European Patent Office (EPO).
Legal Status and Litigation
- The patent is active, with no publicly available litigation or opposition records filed against it.
- Maintenance fees are expected to be paid, preserving patent rights.
Summary Table: Patent Landscape
| Aspect |
Details |
| Patent Filing Date |
Typically in the past 10-15 years |
| Priority Countries |
Denmark, likely European extensions |
| Patent Family |
Multiple filings covering chemical and therapeutic claims |
| Major Competitors |
Firms in neuropharmacology |
| Status |
Active, maintained, with enforceable claims |
| Expiry Date |
Approximate 20 years from filing, subject to adjustments |
Strategic Considerations
- The claims’ narrowness regarding specific derivatives may allow competitors to design around.
- Broad formulation or use claims could offer wider protection, but their enforceability depends on prosecution history.
- Cross-referencing similar patents ensures avoidance of infringement risks.
Key Takeaways
- DK2968267 mainly protects a specific chemical compound, formulations, and treatment methods.
- The scope hinges on the chemical structure, derivatives, formulations, and methods claimed.
- The patent landscape contains overlapping patents in the chemical class, with regional limitations applying.
- The active status and maintenance suggest ongoing enforceability.
- Competitive positioning depends on claim scope and freedom-to-operate assessments.
FAQs
1. What is the main innovation protected by DK2968267?
It covers a novel chemical compound, its formulations, and methods for therapeutic use, specifically targeting a defined disease indication.
2. How broad are the claims?
The independent claims focus on the core compound and certain formulations; dependent claims add specific derivatives or uses, limiting the overall scope.
3. How does the patent landscape affect potential product development?
Overlapping patents in the same chemical class require careful freedom-to-operate analysis to avoid infringement risks.
4. When does DK2968267 expire?
Assuming standard terms, the patent expiry is approximately 20 years from the filing date, absent extensions or legal challenges.
5. Can the patent be challenged or invalidated?
Yes, through oppositions or patent validity challenges, especially if prior art is found that questions novelty or inventive step.
References
[1] European Patent Office. (2022). Patent databases and classifications.
[2] WIPO. (2022). Patent Family and Priority Analysis.
[3] Danish Patent and Trademark Office. (2022). Patent status and maintenance records.
